J Salvat

554 total citations
26 papers, 330 citations indexed

About

J Salvat is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, J Salvat has authored 26 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 8 papers in Reproductive Medicine and 6 papers in Surgery. Recurrent topics in J Salvat's work include Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Gynecological conditions and treatments (5 papers). J Salvat is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Gynecological conditions and treatments (5 papers). J Salvat collaborates with scholars based in France, Switzerland and Luxembourg. J Salvat's co-authors include F McGlynn, Heidi Reich, B. Weber, Éric Pujade-Lauraine, Fabien Tinquaut, Marie‐Christine Guilbert, Aude-Marie Savoye, Olivier Trédan, Emmanuel Sevin and Claire Falandry and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

J Salvat

23 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Salvat France 8 200 196 84 46 37 26 330
Alberto Daniele Italy 7 109 0.5× 108 0.6× 99 1.2× 122 2.7× 20 0.5× 13 276
Marianne J. Rutten Netherlands 10 168 0.8× 279 1.4× 229 2.7× 41 0.9× 31 0.8× 12 403
Ester Miralpeix Spain 10 54 0.3× 79 0.4× 198 2.4× 112 2.4× 41 1.1× 20 364
Gökhan Demirayak Türkiye 11 153 0.8× 83 0.4× 90 1.1× 38 0.8× 33 0.9× 33 288
Rafli van de Laar Netherlands 10 96 0.5× 133 0.7× 108 1.3× 26 0.6× 72 1.9× 16 274
Jeremie Abitbol Canada 13 274 1.4× 217 1.1× 160 1.9× 71 1.5× 19 0.5× 33 438
Oktay Erten Türkiye 9 85 0.4× 198 1.0× 110 1.3× 40 0.9× 65 1.8× 21 314
Rahul A.�K. Samlal Netherlands 11 314 1.6× 204 1.0× 118 1.4× 89 1.9× 27 0.7× 17 411
Ellen Barlow Australia 9 190 0.9× 74 0.4× 123 1.5× 142 3.1× 16 0.4× 18 329
Shayan Dioun United States 9 238 1.2× 187 1.0× 47 0.6× 58 1.3× 27 0.7× 32 346

Countries citing papers authored by J Salvat

Since Specialization
Citations

This map shows the geographic impact of J Salvat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Salvat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Salvat more than expected).

Fields of papers citing papers by J Salvat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Salvat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Salvat. The network helps show where J Salvat may publish in the future.

Co-authorship network of co-authors of J Salvat

This figure shows the co-authorship network connecting the top 25 collaborators of J Salvat. A scholar is included among the top collaborators of J Salvat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Salvat. J Salvat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romieu, Gilles, J Salvat, L. Chaigneau, et al.. (2013). Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer—Study BES 06. Targeted Oncology. 8(2). 137–143. 9 indexed citations
2.
Falandry, Claire, B. Weber, Aude-Marie Savoye, et al.. (2013). Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial. Annals of Oncology. 24(11). 2808–2813. 86 indexed citations
3.
Falandry, Claire, Béatrice Horard, Jérôme Alexandre, et al.. (2012). Correlation of short telomeres (ST) with vulnerability, toxicity, and early death in elderly AOC patients receiving carboplatin: A multicenter GINECO trial.. Journal of Clinical Oncology. 30(15_suppl). 9011–9011. 3 indexed citations
4.
Ray‐Coquard, Isabelle, B. Weber, J Crétin, et al.. (2009). Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group. British Journal of Cancer. 100(4). 601–607. 20 indexed citations
5.
Salvat, J, et al.. (2005). Facteurs du choix de la voie d’abord des hystérectomies pour lésions utérines bénignes (prolapsus et indications obstétricales exclus). Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 34(3). 241–251. 2 indexed citations
6.
Salvat, J, et al.. (2002). [Vascular ligation for severe obstetrical hemorrhage: review of the literature].. PubMed. 31(7). 629–39. 28 indexed citations
7.
Salvat, J. (2001). Diagnostic et suivi de l’endométriose en consultation : nouveautés. Gynécologie Obstétrique & Fertilité. 29(9). 616–623. 3 indexed citations
8.
Salvat, J, et al.. (2001). [Cystic adenoid carcinoma of the endocervix (or cylindroma of the uterine cervix). Exclusive laparoscopic vaginal treatment].. PubMed. 30(2). 180–2. 1 indexed citations
9.
Salvat, J, et al.. (2000). [Voluntary pregnancy termination during 1998 in a French general hospital].. PubMed. 28(1). 23–8. 1 indexed citations
10.
Bolla, M., M. Colonna, Xavier Artignan, et al.. (1999). Pathological prognostic factors in a series of 137 stage I TNM/UICC endometrial carcinomas. Radiotherapy and Oncology. 53(3). 209–211. 3 indexed citations
12.
Bolla, M., et al.. (1996). [Fast growing IB-IIB cancer of the uterine cervix. Apropos of 20 cases].. PubMed. 83(12). 983–7. 1 indexed citations
14.
Bolla, M., M Mousseau, Maria Antonietta Colonna, et al.. (1994). [Modulation of indications of adjuvant hormone therapy with tamoxifen in T1T2/N0N1 breast cancers. Preliminary results of a multicenter study with 695 cases].. PubMed. 81(12). 1085–90. 1 indexed citations
15.
Li, J Salvat, & J Hostein. (1992). [Prevention of recurrent hemorrhages in Rendu-Osler's disease by estrogen-progestative treatment].. PubMed. 16(3). 292–292.
16.
Reich, Heidi, F McGlynn, & J Salvat. (1991). Laparoscopic treatment of cul-de-sac obliteration secondary to retrocervical deep fibrotic endometriosis.. PubMed. 36(7). 516–22. 122 indexed citations
17.
Bolla, M., et al.. (1990). [Inflammatory carcinoma of the uterine cervix. Review of 9 cases].. PubMed. 19(2). 187–91. 2 indexed citations
18.
Salvat, J, et al.. (1988). [Vaginal cesarean sections].. PubMed. 83(6). 423–6. 1 indexed citations
19.
Racinet, C, et al.. (1978). Tubal Sterilization by a Combined Laparoscopic and External Technique: Preliminary Report on 75 Cases. Fertility and Sterility. 30(5). 534–537.
20.
Salvat, J, et al.. (1977). [Indication and technic of tubal sterilization by vaginal route. Posterior transverse colpotomy].. PubMed. 6(6). 851–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026